A homozygous mutation in the insulin gene (INS) causing autosomal recessive neonatal diabetes in Saudi families
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Insulin gene (INS) mutations are a rare cause of permanent neonatal diabetes and mature-onset diabetes of the young (MODY10). Homozygous mutations have been reported to cause diabetes by decreasing insulin biosynthesis through distinct mechanisms. In this study, we report a homozygous mutation c.-331C>G in the INS gene causing autosomal recessive neonatal diabetes in Saudi families and share our experience with diagnosis and management. Methods: We retrospectively reviewed all cases diagnosed with diabetes during the first week of life. We identified 18 cases, and all underwent genetic testing to identify the cause. Most had mutations in common genes (9 in KCNJ11 and 5 in ABCC8). The inclusion criterion for this study was a mutation in the INS gene. Results: Four patients from 3 Saudi families had mutations in the INS gene. All patients were born with low birth weight and were diagnosed with neonatal diabetes at the age of 2 days. Sanger sequencing analysis identified a homozygous INS pathogenic promoter variant, c.-331C>G. All patients were managed by insulin therapy. Two patients had persistent diabetes and in 2 cases diabetes resolved. Conclusion: This report indicates that a homozygous mutation in the INS gene is a probable and important cause of neonatal diabetes in Saudi Arabia. The c.-331C>G variant in the INS gene identified in our study showed variability both within and between families and different outcomes ranging from early resolution of diabetes after 2 months of life to permanent diabetes.
Abstract
Purpose: Insulin gene (INS) mutations are a rare cause of permanent neonatal diabetes and mature-onset diabetes of the young (MODY10). Homozygous mutations have been reported to cause diabetes by decreasing insulin biosynthesis through distinct mechanisms. In this study, we report a homozygous mutation c.-331C>G in the INS gene causing autosomal recessive neonatal diabetes in Saudi families and share our experience with diagnosis and management. Methods: We retrospectively reviewed all cases diagnosed with diabetes during the first week of life. We identified 18 cases, and all underwent genetic testing to identify the cause. Most had mutations in common genes (9 in KCNJ11 and 5 in ABCC8). The inclusion criterion for this study was a mutation in the INS gene. Results: Four patients from 3 Saudi families had mutations in the INS gene. All patients were born with low birth weight and were diagnosed with neonatal diabetes at the age of 2 days. Sanger sequencing analysis identified a homozygous INS pathogenic promoter variant, c.-331C>G. All patients were managed by insulin therapy. Two patients had persistent diabetes and in 2 cases diabetes resolved. Conclusion: This report indicates that a homozygous mutation in the INS gene is a probable and important cause of neonatal diabetes in Saudi Arabia. The c.-331C>G variant in the INS gene identified in our study showed variability both within and between families and different outcomes ranging from early resolution of diabetes after 2 months of life to permanent diabetes.
참고문헌 (15)
- Meur G, "Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention", Diabetes, 59, pp.653~661 (2010)
- Støy J, "Insulin gene mutations as a cause of permanent neonatal diabetes", Proc Natl Acad Sci U S A, 104, pp.15040~15044 (2007)
- Boesgaard TW, "Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY)", BMC Med Genet, 11, pp.42~ (2010)
- Polak M, "Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group", Diabetes, 57, pp.1115~1119 (2008)
- Garin I, "Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis", Proc Natl Acad Sci U S A, 107, pp.3105~3110 (2010)
- Piccini B, "Clinical and molecular characterization of a novel INS mutation identified in patients with MODY phenotype", Eur J Med Genet, 59, pp.590~595 (2016)
- Liu M, "INSgene mutations : from genetics and beta cell biology to clinical disease", Mol Aspects Med, 42, pp.3~18 (2015)
- Liu M, "Proinsulin misfolding and diabetes : mutant INS gene-induced diabetes of youth", Trends Endocrinol Metab, 21, pp.652~659 (2010)
- Ivarsson SA, "Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood", Diabetes, 57, pp.1034~1042 (2008)
- Raile K, "Diabetes caused by insulin gene(INS)deletion : clinical characteristics of homozygous and heterozygous individuals", Eur J Endocrinol, 165, pp.255~260 (2011)
- Støy J, "Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene", Rev Endocr Metab Disord, 11, pp.205~215 (2010)
- Courtney R, "Novel homozygous likely-pathogenic intronic variant in INS causing permanent neonatal diabetes in siblings", J Pediatr Endocrinol Metab, 29, pp.1089~1093 (2016)
- Nishi M, "Insulin gene mutations and diabetes", J Diabetes Investig, 2, pp.92~100 (2011)
- Warsy AS, "Is consanguinity prevalence decreasing in Saudis? A study in two generations", Afr Health Sci, 14, pp.314~321 (2014)
- Alharbi OA, "Attitude of Saudi Arabian adults towards consanguineous marriage", Qatar Med J, 2015, pp.12~ (2015)